387 related articles for article (PubMed ID: 26638918)
1. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
Migliore M; Calvo D; Criscione A; Viola C; Privitera G; Spatola C; Parra HS; Palmucci S; Ciancio N; Caltabiano R; Di Maria G
Future Oncol; 2015; 11(2 Suppl):47-52. PubMed ID: 25662329
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
4. Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
Lim E; Waller D; Lau K; Steele J; Pope A; Ali C; Bilancia R; Keni M; Popat S; O'Brien M; Tokaca N; Maskell N; Stadon L; Fennell D; Nelson L; Edwards J; Tenconi S; Socci L; Rintoul RC; Wood K; Stone A; Muthukumar D; Ingle C; Taylor P; Cove-Smith L; Califano R; Summers Y; Tasigiannopoulos Z; Bille A; Shah R; Fuller E; Macnair A; Shamash J; Mansy T; Milton R; Koh P; Ionescu AA; Treece S; Roy A; Middleton G; Kirk A; Harris RA; Ashton K; Warnes B; Bridgeman E; Joyce K; Mills N; Elliott D; Farrar N; Stokes E; Hughes V; Nicholson AG; Rogers CA;
Lancet Respir Med; 2024 Jun; 12(6):457-466. PubMed ID: 38740044
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies.
Ried M; Potzger T; Braune N; Diez C; Neu R; Sziklavari Z; Schalke B; Hofmann HS
J Surg Oncol; 2013 Jun; 107(7):735-40. PubMed ID: 23386426
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma: Description of pleural decortication and hyperthermic chemotherapy technique in multimodal therapy.
Quiroga NI; Grando LE; Oller XM; Paglialunga PL; Montes ÁG; Sanchez-Lorente D
Multimed Man Cardiothorac Surg; 2024 May; 2024():. PubMed ID: 38747474
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
[TBL] [Abstract][Full Text] [Related]
8. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
[TBL] [Abstract][Full Text] [Related]
9. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
Ishibashi H; Kobayashi M; Takasaki C; Okubo K
Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
[TBL] [Abstract][Full Text] [Related]
10. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
12. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
Burt BM; Richards WG; Lee HS; Bartel S; Dasilva MC; Gill RR; Jaklitsch MT; Johnson BE; Swanson SJ; Bueno R; Sugarbaker DJ
J Thorac Oncol; 2018 Sep; 13(9):1400-1409. PubMed ID: 29753120
[TBL] [Abstract][Full Text] [Related]
13. Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.
Maat A; Durko A; Thuijs D; Bogers A; Mahtab E
Multimed Man Cardiothorac Surg; 2019 Nov; 2019():. PubMed ID: 31751008
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
van Ruth S; Baas P; Haas RL; Rutgers EJ; Verwaal VJ; Zoetmulder FA
Ann Surg Oncol; 2003 Mar; 10(2):176-82. PubMed ID: 12620914
[TBL] [Abstract][Full Text] [Related]
16. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
18. Current surgical strategies for malignant pleural mesothelioma.
Takuwa T; Hasegawa S
Surg Today; 2016 Aug; 46(8):887-94. PubMed ID: 26590581
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
Rojas L; Cardona AF; Trejo-Rosales R; Zatarain-Barrón ZL; Ramírez-Tirado LA; Ruiz-Patiño A; Campos Gómez S; Corrales L; Oblitas G; Bacon L; Martín C; de Lima VCC; Freitas HC; Mas L; Vargas C; Carranza H; Otero J; Pérez MA; González L; Chirinos L; Granados ST; Rodriguez J; Báez R; Remolina Bonilla YA; Núñez Cerrillo G; Archila P; Cuello M; Karachaliou N; Rosell R; Arrieta O;
Thorac Cancer; 2019 Mar; 10(3):508-518. PubMed ID: 30706690
[TBL] [Abstract][Full Text] [Related]
20. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
